Skip to main content
TipRanks
Go Ultimate75% OFF

Endurance RP (RPGLF) AI Stock Analysis

10 Followers
RPGLF

Endurance RP

(Other OTC:RPGLF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
High 2025 Gross MarginThe strong 2025 gross margin indicates that the company can retain substantial value after direct costs when revenue is generated. If sustained and paired with better operating discipline, this could support improved profitability, although past inconsistency limits confidence in its durability.
Negative Factors
Deteriorating ProfitabilityDeepening losses and negative operating earnings show that the business is not converting its revenue base into sustainable profitability. This weakens internal funding capacity and makes future earnings dependent on a meaningful improvement in operating performance rather than gross-margin strength alone.

Endurance RP (RPGLF) vs. SPDR S&P 500 ETF (SPY)

-50%0%50%100%150%200%250%300%350%RPGLF+25.00%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$1.72M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-16.1
Beta (1Y)
-0.86
Revenue Growth
487.27%
EPS Growth
62.36%
Country
US
Employees
17
Sector
Healthcare
Sector Strength
51
Industry
Medical - Pharmaceuticals

Endurance RP Business Overview & Revenue Model

Company Description

Regent Pacific Group Limited is an investment holding company that primarily focuses on the healthcare and life sciences sectors. The company is involved in the research, development, and sale of pharmaceutical products, with a notable focus on treat...

Endurance RP Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

RPGLF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:1217HK:121775OutperformHKD 128.02M-4.54-4.90%―-126.01%-237.50%
HK:0310HK:031052NeutralHKD 79.50M-6.21-82.36%――79.32%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:0129HK:012946NeutralHKD 220.20M-0.12-16.70%―163.09%52.42%
HK:0339HK:033937UnderperformHKD 123.12M-16.86-66.95%――-700.00%
HK:1835HK:183531UnderperformHKD 685.43M-18.63-13.47%―40.35%-327.36%

* Healthcare Sector Average

Performance Comparison

0%200%400%RPGLFHK:0129HK:1217HK:1835HK:0310HK:0339Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
RPGLF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
RPGLFEndurance Rp Limited0.130.0225.00%
HK:0129Asia Standard International Group 0.15-0.13-46.55%
HK:1217China Innovation Investment Limited0.01-0.00-28.57%
HK:1835Shanghai Realway Capital Assets Management Co., Ltd. Class H4.472.43119.12%
HK:0310Prosperity Investment Holdings Limited0.13-0.06-30.81%
HK:0339Core Economy Investment Group Limited0.280.1491.28%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.